This company seems to have been delisted
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Genocea Biosciences
GNCA
₹0.008708
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Earnings for Genocea Biosciences (GNCA)
Earnings in 2022 (TTM): -₹2.8 Billion
According to Genocea Biosciences 's latest financial reports the company's current earnings are ₹1.91 Million. In 2021 the company made an earning of -₹2.9 Billion, an increase over its 2020 earnings that were of -₹3.81 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genocea Biosciences from 2013 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -₹2.8 Billion | -3.45% |
| 2021 | -₹2.9 Billion | -24.06% |
| 2020 | -₹3.81 Billion | 12.23% |
| 2019 | -₹3.4 Billion | 40.05% |
| 2018 | -₹2.43 Billion | -50.96% |
| 2017 | -₹4.94 Billion | 14.4% |
| 2016 | -₹4.32 Billion | 16.69% |
| 2015 | -₹3.7 Billion | 20.36% |
| 2014 | -₹3.08 Billion | 69.64% |
| 2013 | -₹1.82 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Agenus
AGEN | -₹8.21 Billion | 153.37% | 🇺🇸 USA |
 Novavax NVAX | ₹44.42 B | -1,471.85% | 🇺🇸 USA |
 Merck MRK | ₹1.867 T | -57,775.24% | 🇺🇸 USA |
 iBio IBIO | -₹1.42 Billion | -56.36% | 🇺🇸 USA |
 Pfizer PFE | ₹900.49 B | -27,905.11% | 🇺🇸 USA |